Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11939331 Tricyclic heterocycles as FGFR inhibitors

Patent 11939331 was granted and assigned to Incyte on March, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 23 Oct, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 23 Oct, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12122767 Bicyclic heterocycles as FGFR inhibitors
0
Edits on 29 Mar, 2024
"Created via: Patent importer"
Golden AI profile picture
Golden AI
created this topic on 29 Mar, 2024
Edits made to:
Infobox (+71 properties)
‌

 US Patent 11939331 Tricyclic heterocycles as FGFR inhibitors

Infobox
Is a
Patent
Patent
0
Patent Applicant
Incyte
Incyte
0
Current Assignee
Incyte
Incyte
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
119393310
Patent Inventor Names
Evan Styduhar0
Oleg Vechorkin0
Robert Swyka0
Wenqing Yao0
Xin Li0
Date of Patent
March 26, 2024
0
Patent Application Number
178353310
Date Filed
June 8, 2022
0
Patent Citations
‌
US Patent 7125880 Corticotropin releasing factor antagonists
0
‌
US Patent 11173162 Bicyclic heterocycles as FGFR4 inhibitors
0
‌
US Patent 11174257 Salts of an FGFR inhibitor
0
‌
US Patent 7488802 Antibodies against PD-1
0
‌
US Patent 7618975 4-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis and the use thereof
0
‌
US Patent 7642255 Compounds and compositions as protein kinase inhibitors
0
‌
US Patent 7648973 2-methylene-1α,25-dihydroxy-19,21-dinorvitamin D
0
‌
US Patent 7943743 Human monoclonal antibodies to programmed death ligand 1 (PD-L1)
0
‌
US Patent 8008449 Human monoclonal antibodies to programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics
0
‌
US Patent 8168757 PD-1 binding proteins
0
‌
US Patent 8217149 Anti-PD-L1 antibodies, compositions and articles of manufacture
0
‌
US Patent 8754114 Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
0
‌
US Patent 8759398 Phosphorus binder composition for treatment of hyperphosphatemia
0
‌
US Patent 8889711 Pyrazolopyridine derivatives as anticancer agent
0
‌
US Patent 9266892 Fused pyrazoles as FGFR inhibitors
0
‌
US Patent 9388185 Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
0
‌
US Patent 9533954 Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
0
‌
US Patent 9533984 Bicyclic heterocycles as FGFR inhibitors
0
‌
US Patent 9580423 Bicyclic heterocycles as FGFR4 inhibitors
0
‌
US Patent 9611267 Substituted tricyclic compounds as FGFR inhibitors
0
‌
US Patent 9708318 Bicyclic heterocycles as FGFR4 inhibitors
0
‌
US Patent 9745311 Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
0
‌
US Patent 9801889 Bicyclic heterocycles as FGFR4 inhibitors
0
‌
US Patent 9890156 Bicyclic heterocycles as FGFR4 inhibitors
0
‌
US Patent 10016348 Two-phase composition comprising a fatty acid ester of sugar or a liquid alkyl polyglucoside, with an HLB < 8, and a C
0
‌
US Patent 10040790 Bicyclic heterocycles as FGFR inhibitors
0
‌
US Patent 10131667 Substituted tricyclic compounds as FGFR inhibitors
0
‌
US Patent 10208024 2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases
0
‌
US Patent 10213427 Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
0
‌
US Patent 10214528 Bicyclic heterocycles as FGFR4 inhibitors
0
‌
US Patent 10251892 Bicyclic heterocycles as FGFR4 inhibitors
0
‌
US Patent 10308644 Heterocyclic compounds as immunomodulators
0
‌
US Patent 10350240 Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and use
0
‌
US Patent 10357431 Process for the preparation of a pharmaceutical composition comprising a low soluble pharmaceutically active ingredient
0
‌
US Patent 10450313 Bicyclic heterocycles as FGFR inhibitors
0
‌
US Patent 10611762 Crystalline forms of a FGFR inhibitor and processes for preparing the same
0
‌
US Patent 10632126 Bicyclic heterocycles as FGFR4 inhibitors
0
‌
US Patent 10738048 Bicyclic heterocycles as FGFR4 inhibitors
0
‌
US Patent 10813930 Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
0
‌
US Patent 10851105 Bicyclic heterocycles as FGFR4 inhibitors
0
‌
US Patent 10947230 Bicyclic heterocycles as FGFR inhibitors
0
‌
US Patent 11014923 Bicyclic heterocycles as FGFR4 inhibitors
0
‌
US Patent 11053246 Substituted tricyclic compounds as FGFR inhibitors
0
‌
US Patent 11407750 Derivatives of an FGFR inhibitor
0
‌
US Patent 11466004 Solid forms of an FGFR inhibitor and processes for preparing the same
0
‌
US Patent 11607416 Bicyclic heterocycles as FGFR inhibitors
0
‌
US Patent 6998408 6-5, 6-6, or 6-7 Heterobicycles as factor Xa inhibitors
0
‌
US Patent 7074801 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof
0
Patent Primary Examiner
‌
John M Mauro
0
CPC Code
‌
C07D 471/14
0
‌
C07D 519/00
0
‌
A61P 35/00
0
‌
A61K 31/541
0
‌
A61K 31/5377
0
‌
A61K 31/506
0
‌
A61K 31/496
0
‌
A61K 31/439
0
‌
A61K 31/4375
0

Find more entities like US Patent 11939331 Tricyclic heterocycles as FGFR inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo